Intermittent Chemotherapy With or Without Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) for Metastatic Hormone Refractory Prostate Cancer (HRPC)

NCT00488982 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

125

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Docetaxel
DRUG: Docetaxel and GM-CSF

Sponsor

University of California, San Francisco

Collaborators

[object Object]